FORTE Study Updates: February 2025 Newsletter

February 18 2025

NRG Oncology Partners with TravaLab to offer Mobile Phlebotomy

FORTE is offering sites the opportunity to implement remote blood draws with participants enrolled in NRG-CC005. NRG Oncology is working with TravaLab, an online portal that offers mobile phlebotomy services nationwide, to conduct blood draws for FORTE. This process will complement remote consent processes at all participating sites to increase overall accrual to NRG-CC005.

No additional contracting or payment is required for sites to use this service, but you must opt-in for the service by notifying NRG Oncology. Opting in does not obligate you to use the service. Review the revised NRG-CC005 funding sheet on CTSU for payment information with TravaLab.

The FORTE team has created the FORTE TravaLab Manual - Mobile Phlebotomy to guide sites on implementing mobile phlebotomy. Review this document to determine if your site may partner with TravaLab to offer this service to your participants.

To get started with TravaLab, fill out the TravaLab Registration Form on CTSU and submit it to forte@nrgoncology.org.

FORTE Site Call 

Join the quarterly FORTE site calls to hear updates on NRG-CC005 and discuss challenges and solutions with other research professionals working to enroll patients to this clinical trial. Registration for these virtual sessions are in these monthly FORTE Fridays broadcasts. 

Accrual Updates and Milestones (as of February 3, 2025)

Top accruing sites:

  • Kaiser Permanente – Vallejo – 1326 accrued
  • UPMC-Presbyterian Hospital – 275 accrued
  • Regions Hospital – 116 accrued

Most recent randomizations:

  • Kaiser Permanente-Vallejo – January 31, 2025
  • Boston Veteran's Affairs Medical Center – January 31, 2025
  • Kansas City Veterans Affairs Medical Center – January 30, 2025

FORTE Resource Portal

Bookmark this website, that organizes materials found on CTSU: https://www.nrgoncology.org/Clinical-Trials/NRG-CC005/FORTE-Resource-Portal. You will use the same login information as for CTSU to access this page. Once you gain access, the “FORTE Materials for Research Professionals” section contains many materials to assist you with accruing participants. This website also has contact information for questions you may have while working on NRG-CC005.

Find both CIRB-approved and protocol-related documents on CTSU under NRG-CC005.

Do you have new research team members working on NRG-CC005?

Clinical research professionals can sign up for NRG Weekly Broadcasts to receive FORTE Fridays updates directly to your inbox: https://www.nrgoncology.org/Home/News/Weekly-Broadcasts.

Questions from Site Research Staff

If research staff have questions about a patient's eligibility or study logistics for the NRG-CC005/FORTE Study, contact the Clinical Coordinating Department (CCD) at: FORTE@nrgoncology.org or 1(800) 477-7227.

Stay current with science. Sign up for our newsletter.

Support NRG Oncology.
Help Our Cause.

We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More

Donate Today

NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.